FEVRX | FSIDX | FEVRX / FSIDX | |
Total Expense Ratio | 0.84 | 0.67 | 125% |
Annual Report Gross Expense Ratio | 0.84 | 0.67 | 125% |
Fund Existence | 8 years | 21 years | - |
Gain YTD | 6.412 | 3.014 | 213% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.44B | 5.13B | 28% |
Annual Yield % from dividends | 1.73 | 2.47 | 70% |
Returns for 1 year | 8.02 | 6.34 | 126% |
Returns for 3 years | 16.12 | 13.79 | 117% |
Returns for 5 years | 37.76 | 31.19 | 121% |
Returns for 10 years | N/A | 42.94 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BGIVX | 15.87 | 0.04 | +0.23% |
Baillie Gifford International Alpha 5 | |||
LEXCX | 64.06 | N/A | N/A |
Voya Corporate Leaders Trust B | |||
IJEAX | 12.74 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity A | |||
VLPCX | 16.29 | N/A | N/A |
Virtus Duff & Phelps Sel MLP & Engy C | |||
ODVNX | 39.78 | N/A | N/A |
Invesco Developing Markets R |